Joseph Jimenez

From Wikipedia, the free encyclopedia
This article is about the businessman. For the golfer, see Joe Jimenez. For the baseball player, see Joe Jiménez.
Joseph Jimenez
Joseph Jimenez at the World Economic Forum.jpg
Jimenez at the World Economic Forum in 2017
NationalityAmerican
Alma materStanford University
University of California, Berkeley[1]
OccupationFormer CEO of Novartis

Joseph Jimenez is the former CEO of the American Swiss pharmaceutical company Novartis.[2]

Education[]

Jimenez earned a bachelor's degree from Stanford University in 1982, and an MBA from University of California, Berkeley's Haas School of Business in 1984.[3]

Career[]

Early career[]

Jimenez began his career at Clorox before joining ConAgra Foods.[4][5][6]Prior to joining Novartis, he was head of H. J. Heinz Company's North American business from 2002 to 2006. He was also a non-executive director of AstraZeneca from 2002 to 2007, as well as an advisor for the Blackstone Group.[5]

Novartis[]

Jimenez joined Novartis in 2007 as Division Head of Novartis Pharmaceutical and was named CEO in 2010[7] by his predecessor and Chairman Daniel Vasella.[8]

During his time at Novartis, Jimenez increasingly applied standard business metrics to pharma cash flow, purchasing and competitive bidding, confident that his experience in consumer goods would help to realize improvements in Novartis' operations. His cost-cutting moves, focused mostly on marketing and administration, came steadily, with more than a billion cut in 2010, and even more than that in 2011.[9]

Jimenez joined the board of directors at General Motors on June 9, 2015[10]

Jimenez resigned from Novartis, leaving in February 2018, and was succeeded by Vasant Narasimhan.[11][12]

He joined the Board of Directors of San Francisco biotech startup uBiome in September 2018 and stepped down in April 2019 to start the biotech venture fund Aditum Bio.[13]

References[]

  1. ^ http://www.novartisfoundation.org/platform/content/element/4381/bio_jimenez_e_final.pdf
  2. ^ Bryant, Adam (8 October 2011). "Fix the Problem, and Not Just the Symptoms". New York Times. Retrieved 22 May 2013.
  3. ^ "Joseph Jimenez MBA". Businessweek. Retrieved 22 May 2013.
  4. ^ "Joseph Jimenez - Forbes". People.forbes.com. 2012-04-18. Archived from the original on April 2, 2009. Retrieved 2012-08-02.
  5. ^ a b "P&G investors wish for CEO Joe Jimenez as outgoing Novartis chief joins board". FiercePharma. Retrieved 2021-07-27.
  6. ^ Buck, Jonathan. "Novartis CEO Writes a Prescription for the Swiss Drug Giant's Success". online.barrons.com. Retrieved 2021-07-27.
  7. ^ "Joseph Jimenez - The 25 most influential people in biopharma today". Fierce Biotech. Retrieved 22 May 2013.
  8. ^ Greil, Anita (2010-01-26). "Vasella's Impeccable Timing - The Source - WSJ". Blogs.wsj.com. Retrieved 2012-08-02.
  9. ^ "Joseph Jimenez - The 25 most influential people in biopharma today - FierceBiotech". www.fiercebiotech.com.
  10. ^ https://web.archive.org/web/20150906055830/http://www.gm.com/company/aboutGM/board_of_directors0/joseph_jimenez.html. Archived from the original on 2015-09-06. {{cite web}}: Missing or empty |title= (help)
  11. ^ "Novartis CEO Jimenez to Quit, Giving Reins to Harvard Doctor". Bloomberg.com. Bloomberg Technology. 4 September 2017. Retrieved 5 September 2017.
  12. ^ Roland, Denise (2017-09-04). "Novartis CEO to Step Down in January". Wall Street Journal. ISSN 0099-9660. Retrieved 2020-05-07.
  13. ^ Al Idrus, Amirah. "Biotech Novartis alums Jimenez, Fishman unveil their next act: Aditum Bio". Fierce Biotech. Questex. Retrieved Nov 3, 2020.

External links[]

Retrieved from ""